Needle Market Outlook Signals Expansion To $12.26 Billion Through 2030

The needle market is positioned for significant expansion over the coming years, driven by evolving healthcare practices and increasing demand for safer, more effective medical devices. As healthcare systems worldwide emphasize improved patient care and safety, the needle market is responding with innovation and growth opportunities. Let's explore the current market size, key drivers, prominent players, emerging trends, and segmentation within this vital industry.

Projected Growth Trajectory of the Needle Market by 2030
The needle market is forecasted to reach a substantial valuation of $12.27 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.6% during the forecast period. This upward trend is fueled by heightened attention to protecting healthcare workers, expanding use of home-based care and self-injection methods, rising global diabetes rates, growth in outpatient and ambulatory care, and an increasing preference for minimally invasive medical procedures. Among the notable market trends are the wider adoption of safety needles designed to prevent needle-stick injuries, a rising need for disposable and single-use needles, increased use of pen needles specifically for diabetes, greater application of needles in blood collection and diagnostic contexts, and a growing inclination towards sterile, pre-packaged needle products.

Download a free sample of the Needle market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15614&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Core Factors Encouraging Needle Market Expansion
A key driver for the needle market is the increasing focus on healthcare worker safety, prompting demand for safety-engineered needles that help reduce injuries and infections. This shift highlights the healthcare sector's commitment to creating safer working environments amid rising patient care demands.
Additionally, the rise in home-based healthcare and the adoption of self-injection therapies, particularly for chronic diseases like diabetes, are significantly contributing to market growth. Patients are seeking convenient and user-friendly needle options that support independent treatment outside traditional clinical settings.

Leading Needle Market Players Shaping Industry Dynamics
The needle market features a competitive lineup of major companies such as Becton dic*kinson, Terumo Corporation, B. Braun AG, NIPRO Corporation, Smiths Medical, Cardinal Health, Hindustan Syringes and Medical Devices, Retractable Technologies, Owen Mumford, Ypsomed, Vygon, ICU Medical, Novo Nordisk, Medtronic, Boston Scientific, Cook Medical, Stryker, Teleflex, Nipro Medical Europe, and Baxter International.
An important recent development occurred in August 2024 when Medical Technology and Devices S.p.A. (MTD), an Italy-based manufacturer, acquired Ypsomed's pen-needle and blood-glucose-monitoring (BGM) business. This acquisition enhances MTD's pen-needle production capabilities to over 2.5 billion units, strengthening its standing as a global leader in pen needle manufacturing. Ypsomed Holding AG, based in Switzerland, is renowned for its diabetes care technologies, including injection and monitoring devices.

View the full Needle market report:
https://www.thebusinessresearchcompany.com/report/needle-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Innovations and Advances Driving Positive Market Momentum
Companies in the needle market are increasingly prioritizing innovation, particularly in developing advanced conventional transbronchial needles that are transforming minimally invasive diagnostic procedures. These needles are critical in bronchoscopy for obtaining tissue samples from lungs and nearby tissues.
For example, in September 2023, US-based Broncus Medical Inc. launched the BIOSTAR line of needles, which includes conventional transbronchial needle aspiration (cTBNA) and endobronchial ultrasound-guided TBNA (EBUS-TBNA) devices. These needles significantly improve diagnostic accuracy, sample adequacy, and sensitivity, especially in lung cancer staging and sarcoidosis diagnoses. Available in sizes 25G, 22G, 21G, and 19G, they allow clinicians to select the optimal gauge based on sample needs, blood aspiration, and diagnostic goals. BIOSTAR represents a major leap forward in minimally invasive diagnostics, enhancing both patient outcomes and clinical efficiency.

Market Segmentation Highlighting Larger Shares in Needle Types and Uses
The needle market is organized into several key segments:
1) By Type - Conventional Needles and Safety Needles.
2) By Application - Pen Needles for Diabetes, Blood Collection Needles, Ophthalmic Procedure Needles, and Dentistry Needles.
3) By End User - Hospitals, Clinics, Diagnostic Centers, and Home-Based Care.
Within Conventional Needles, subcategories include Hypodermic Needles, Intravenous (IV) Needles, Insulin Needles, and Blood Collection Needles. Safety Needles are further divided into Safety Hypodermic Needles, Safety Insulin Needles, Safety Blood Collection Needles, and Auto-Disable Safety Needles. This comprehensive segmentation helps capture the diverse needs across clinical and patient care settings, with each segment reflecting specific demands and safety concerns.

Regional and Sectoral Insights Into Needle Market Growth
While specific regional data is not outlined here, the global needle market's expansion is supported by rising healthcare infrastructure investments, increasing chronic disease prevalence, and growing awareness about safety and sterile medical devices across multiple healthcare environments. This broad-based demand positions the needle market for sustained growth through 2030, driven by innovation, evolving healthcare delivery models, and expanding patient populations requiring injections and minimally invasive procedures.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.